Product Data Sheet

NYX-2925

Catalog No. A67148

main product photo
NYX-2925 is an orally active NMDAR modulator that specifically restores activated Src and its phosphorylation sites on GluN2A and GluN2B in the medial prefrontal cortex. This compound does not affect CAMKII and is devoid of addictive, sedative, or ataxic side effects. NYX-2925 is a valuable tool for investigating NMDA receptor-related central nervous system disorders.
Chemical Information
Catalog NumA67148
M. Wt297.35
FormulaC14H23N3O4
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2012536-16-0
Synonyms
SMILESCC(C)C(N1[C@@]2(CCC1)C(N(C2)[C@H](C(N)=O)[C@H](O)C)=O)=O
Biological Activity
DescriptionNYX-2925 is an orally active NMDAR modulator that specifically restores activated Src and its phosphorylation sites on GluN2A and GluN2B in the medial prefrontal cortex. This compound does not affect CAMKII and is devoid of addictive, sedative, or ataxic side effects. NYX-2925 is a valuable tool for investigating NMDA receptor-related central nervous system disorders.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.